FDA Investigator Michelle M Parisi
Michelle M Parisi has conducted inspections on 8 sites in 1 countries as of 25 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Michelle M Parisi:
Addam S Reynolds,
Alois P Provost,
Amy L Singer,
Amy M Cramer,
Annemarie Bodnar,
Atul J Agrawal,
Byungja E Marciante,
David A Schwartz,
Dhaval H Patel,
Edward O'shaughnessy,
Frank J Marciniak,
Frederick F Razzaghi,
Gobiga Vanniyasingam,
Jennifer Macmillan,
Jessica M Monteiro,
Joy Rkozlowski Klena,
Kelli F Dobilas,
Kristen E Rescigno,
Marea K Harmon,
Margaret M Sands,
Maria A Bienkowski,
Maria A Reed,
Nerizza B Guerin,
Nicholas A Violand,
Peter R Lenahan,
Raymond L Cheung,
Richard D Manney,
Russell J Glapion,
Sarah Forney,
Schultz,
Valerie C Reed,
Wayne J Meyer
Michelle M Parisi's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2009 | FDA 483 Response | RMJ Laboratories, Inc. - Form 483R, 2009-05-28 |
May, 2009 | FDA 483 | RMJ Laboratories, Inc. - Form 483, 2009-05-28 |
June, 2009 | FDA 483 | Propak Development, Inc. - Form 483, 2009-06-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more